Get startedLog in
    Picture of Cytokinetics, Incorporated logo

    CYTK — Cytokinetics, Incorporated News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: Cytokinetics Announces European Commission Approval Of MYQORZO

    Picture of Cytokinetics, Incorporated logoCytokinetics, Incorporated
    17/02/2026 13:26
    Feb 17 (Reuters) - Cytokinetics Inc CYTK.O:

CYTOKINETICS ANNOUNCES EUROPEAN COMMISSION APPROVAL OF MYQORZO® (AFICAMTEN) FOR THE TREATMENT OF ADULTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

CYTOKINETICS INC: FIRST EUROPEAN LAUNCH EXPECTED IN GERMANY IN Q2 2026

Source text: ID:nGNXbhJ25h

Further company coverage: CYTK.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Cytokinetics, Incorporated

    See all news